In this year’s report, OCP celebrates its 30th anniversary, showcasing the Office’s contributions to the evolution of clinical pharmacology into a foundational pillar of drug development and regulatory review by enhancing efficacy and safety evaluations through rigorous, collaborative, and state-of-the-art approaches.